FutureMeds expand capacity, reach & capabilities.
FutureMeds are delighted to announce the acquisition of KCM, a leading clinical trial site based in Krakow, Poland. KCM was founded in 1994 and has successfully completed over 200 clinical trials. The site significantly increases our capacity and therapy area coverage and we look forward to working with Professor Czerwinski and his excellent team.
FutureMeds are also in advanced discussions with a number of other parties as we continue to build our site network across Europe to best serve our clients.